Literature DB >> 27590102

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report.

Bronwen E Shaw1, Theresa Hahn2, Paul J Martin3, Sandra A Mitchell4, Effie W Petersdorf3, Gregory T Armstrong5, Nonniekaye Shelburne6, Barry E Storer7, Smita Bhatia8.   

Abstract

The increasing numbers of hematopoietic cell transplantations (HCTs) performed each year, the changing demographics of HCT recipients, the introduction of new transplantation strategies, incremental improvement in survival, and the growing population of HCT survivors demand a comprehensive approach to examining the health and well-being of patients throughout life after HCT. This report summarizes strategies for the conduct of research on late effects after transplantation, including consideration of the study design and analytic approaches; methodologic challenges in handling complex phenotype data; an appreciation of the changing trends in the practice of transplantation; and the availability of biospecimens to support laboratory-based research. It is hoped that these concepts will promote continued research and facilitate the development of new approaches to address fundamental questions in transplantation outcomes.
Copyright © 2017 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hematopoietic cell transplantation; Late effects; National Institutes of Health consensus

Mesh:

Year:  2016        PMID: 27590102      PMCID: PMC5182148          DOI: 10.1016/j.bbmt.2016.08.018

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  24 in total

Review 1.  Alternative donor transplantation for adults with acute leukemia.

Authors:  Frederick R Appelbaum
Journal:  Best Pract Res Clin Haematol       Date:  2014-10-15       Impact factor: 3.020

2.  Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the Bone Marrow Transplant Survivor study.

Authors:  James G Gurney; Kirsten K Ness; Joseph Rosenthal; Stephen J Forman; Smita Bhatia; K Scott Baker
Journal:  Cancer       Date:  2006-03-15       Impact factor: 6.860

3.  Solid cancers after bone marrow transplantation.

Authors:  R E Curtis; P A Rowlings; H J Deeg; D A Shriner; G Socíe; L B Travis; M M Horowitz; R P Witherspoon; R N Hoover; K A Sobocinski; J F Fraumeni; J D Boice
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

4.  Peripheral-blood stem cells versus bone marrow from unrelated donors.

Authors:  Claudio Anasetti; Brent R Logan; Stephanie J Lee; Edmund K Waller; Daniel J Weisdorf; John R Wingard; Corey S Cutler; Peter Westervelt; Ann Woolfrey; Stephen Couban; Gerhard Ehninger; Laura Johnston; Richard T Maziarz; Michael A Pulsipher; David L Porter; Shin Mineishi; John M McCarty; Shakila P Khan; Paolo Anderlini; William I Bensinger; Susan F Leitman; Scott D Rowley; Christopher Bredeson; Shelly L Carter; Mary M Horowitz; Dennis L Confer
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

5.  Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study.

Authors:  K Scott Baker; James G Gurney; Kirsten K Ness; Ravi Bhatia; Stephen J Forman; Liton Francisco; Philip B McGlave; Leslie L Robison; David S Snyder; Daniel J Weisdorf; Smita Bhatia
Journal:  Blood       Date:  2004-06-01       Impact factor: 22.113

Review 6.  Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist.

Authors:  Natasha Kekre; Joseph H Antin
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

Review 7.  Conditioning regimens for hematopoietic cell transplantation: one size does not fit all.

Authors:  Boglarka Gyurkocza; Brenda M Sandmaier
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

8.  Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age.

Authors:  Philip L McCarthy; Theresa Hahn; Anna Hassebroek; Christopher Bredeson; James Gajewski; Gregory Hale; Luis Isola; Hillard M Lazarus; Stephanie J Lee; Charles F Lemaistre; Fausto Loberiza; Richard T Maziarz; J Douglas Rizzo; Steven Joffe; Susan Parsons; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2013-05-06       Impact factor: 5.742

Review 9.  Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention.

Authors:  Joseph Pidala; Claudio Anasetti; Heather Jim
Journal:  Br J Haematol       Date:  2009-11-16       Impact factor: 6.998

10.  Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.

Authors:  J R Passweg; H Baldomero; P Bader; C Bonini; S Cesaro; P Dreger; R F Duarte; C Dufour; J Kuball; D Farge-Bancel; A Gennery; N Kröger; F Lanza; A Nagler; A Sureda; M Mohty
Journal:  Bone Marrow Transplant       Date:  2016-02-22       Impact factor: 5.483

View more
  6 in total

1.  Healthcare Costs and Utilization for Patients Age 50 to 64 Years with Acute Myeloid Leukemia Treated with Chemotherapy or with Chemotherapy and Allogeneic Hematopoietic Cell Transplantation.

Authors:  Jaime M Preussler; Christa L Meyer; Lih-Wen Mau; Navneet S Majhail; Ellen M Denzen; Kristen C Edsall; Stephanie H Farnia; Wael Saber; Linda J Burns; David J Vanness
Journal:  Biol Blood Marrow Transplant       Date:  2017-03-02       Impact factor: 5.742

Review 2.  Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.

Authors:  Minoo Battiwalla; André Tichelli; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2016-11-03       Impact factor: 5.742

3.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes.

Authors:  Minoo Battiwalla; Shahrukh Hashmi; Navneet Majhail; Steven Pavletic; Bipin N Savani; Nonniekaye Shelburne
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-29       Impact factor: 5.742

Review 4.  Long-term complications after hematopoietic cell transplantation.

Authors:  Navneet S Majhail
Journal:  Hematol Oncol Stem Cell Ther       Date:  2017-06-13

Review 5.  Late effects of blood and marrow transplantation.

Authors:  Yoshihiro Inamoto; Stephanie J Lee
Journal:  Haematologica       Date:  2017-02-23       Impact factor: 9.941

6.  Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia.

Authors:  Johannes Schetelig; Liesbeth C de Wreede; Michel van Gelder; Linda Koster; Jürgen Finke; Dietger Niederwieser; Dietrich Beelen; G J Mufti; Uwe Platzbecker; Arnold Ganser; Silke Heidenreich; Johan Maertens; Gerard Socié; Arne Brecht; Matthias Stelljes; Guido Kobbe; Liisa Volin; Arnon Nagler; Antonin Vitek; Thomas Luft; Per Ljungman; Ibrahim Yakoub-Agha; Marie Robin; Nicolaus Kröger
Journal:  Leukemia       Date:  2018-12-20       Impact factor: 11.528

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.